Form of proxy for use by shareholders at the 2026 EGM (or any adjournment thereof) to be held at 4: 00 p.m. on Friday, October 30, 2026
Filed with HKEX · Stock code 1779 · · 1 page · English
Summary by 6ix AI
This filing is a proxy form for shareholders of LongBio Pharma (Suzhou) Co., Ltd. to use at the upcoming extraordinary general meeting. The meeting is scheduled to take place in the afternoon on a specified date in October. Shareholders can appoint a proxy to attend and vote on their behalf, with specific resolutions outlined for approval. The document includes instructions for completing the proxy form and details on personal information collection.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
LongBio Pharma (Suzhou) Co., Ltd. on 6ix
Earlier from LongBio Pharma (Suzhou)
- Notice of extraordinary general meeting
- Proposed amendments to the articles of association and notice of extraordinary general meeting
- Proposed amendments to the articles of association
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- 2026 Interim report
Later from LongBio Pharma (Suzhou)
All LongBio Pharma (Suzhou) news releasesFollow LongBio Pharma (Suzhou) into a list and get an email when it puts out news.
Follow LongBio Pharma (Suzhou)